Related Experiment Video

Updated: Aug 6, 2026

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

Diffuse panbronchiolitis--pathophysiology and treatment mechanisms

K Yanagihara1, J Kadoto, S Kohno

  • 1Second Department of Internal Medicine, Nagasaki University School of Medicine, 7-1 Sakamoto 1-Chome, Nagasaki 852, Japan.

International Journal of Antimicrobial Agents
|September 28, 2001
PubMed

Insights

Diffuse panbronchiolitis (DPB) is a serious lung disease. Long-term, low-dose macrolide therapy significantly improves outcomes for DPB patients, potentially through anti-inflammatory effects.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Diffuse panbronchiolitis (DPB) is a chronic, severe lower respiratory disease prevalent in Japanese populations.
  • DPB involves chronic inflammatory cell infiltration, with Pseudomonas aeruginosa sometimes present.
  • Bronchoalveolar lavage fluid shows elevated neutrophils, lymphocytes, and cytokines in DPB compared to other chronic lung diseases.

Purpose of the Study:

  • To investigate the therapeutic effects of macrolides in diffuse panbronchiolitis.
  • To explore the potential anti-inflammatory mechanisms of macrolides in DPB treatment.

Main Methods:

  • Analysis of bronchoalveolar lavage fluid composition in DPB patients.
  • Evaluation of treatment outcomes with long-term, low-dose macrolide therapy.
  • Assessment of macrolide efficacy in the presence and absence of Pseudomonas aeruginosa infection.

Main Results:

  • Long-term, low-dose macrolide therapy demonstrably improves prognosis in DPB.
  • Macrolides show effectiveness even when Pseudomonas aeruginosa is not detected.
  • Evidence suggests macrolides exert anti-inflammatory actions in DPB.

Conclusions:

  • Macrolide therapy is a crucial treatment for improving outcomes in diffuse panbronchiolitis.
  • The anti-inflammatory properties of macrolides likely contribute to their efficacy in DPB.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...